Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 9 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | yes | yes: 11, no: 0 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4HQ81
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 159 | 163 | PF00656 | 0.542 |
CLV_C14_Caspase3-7 | 225 | 229 | PF00656 | 0.520 |
CLV_C14_Caspase3-7 | 289 | 293 | PF00656 | 0.408 |
CLV_NRD_NRD_1 | 36 | 38 | PF00675 | 0.669 |
CLV_PCSK_SKI1_1 | 136 | 140 | PF00082 | 0.309 |
CLV_PCSK_SKI1_1 | 269 | 273 | PF00082 | 0.557 |
DEG_APCC_DBOX_1 | 276 | 284 | PF00400 | 0.393 |
DEG_SCF_FBW7_2 | 199 | 204 | PF00400 | 0.309 |
DOC_CYCLIN_yCln2_LP_2 | 42 | 48 | PF00134 | 0.583 |
DOC_MAPK_gen_1 | 145 | 155 | PF00069 | 0.521 |
DOC_MAPK_gen_1 | 37 | 44 | PF00069 | 0.464 |
DOC_MAPK_MEF2A_6 | 132 | 139 | PF00069 | 0.584 |
DOC_MAPK_MEF2A_6 | 37 | 44 | PF00069 | 0.498 |
DOC_MAPK_NFAT4_5 | 37 | 45 | PF00069 | 0.410 |
DOC_PIKK_1 | 86 | 93 | PF02985 | 0.308 |
DOC_PP2B_LxvP_1 | 42 | 45 | PF13499 | 0.495 |
DOC_PP2B_LxvP_1 | 96 | 99 | PF13499 | 0.264 |
DOC_PP4_FxxP_1 | 100 | 103 | PF00568 | 0.283 |
DOC_PP4_FxxP_1 | 196 | 199 | PF00568 | 0.505 |
DOC_USP7_MATH_1 | 123 | 127 | PF00917 | 0.439 |
DOC_USP7_MATH_2 | 232 | 238 | PF00917 | 0.384 |
DOC_WW_Pin1_4 | 197 | 202 | PF00397 | 0.460 |
LIG_14-3-3_CanoR_1 | 108 | 113 | PF00244 | 0.276 |
LIG_14-3-3_CanoR_1 | 6 | 16 | PF00244 | 0.586 |
LIG_Actin_WH2_2 | 210 | 226 | PF00022 | 0.598 |
LIG_BRCT_BRCA1_1 | 189 | 193 | PF00533 | 0.313 |
LIG_FHA_1 | 10 | 16 | PF00498 | 0.635 |
LIG_FHA_1 | 123 | 129 | PF00498 | 0.437 |
LIG_FHA_1 | 150 | 156 | PF00498 | 0.487 |
LIG_FHA_2 | 289 | 295 | PF00498 | 0.603 |
LIG_LIR_Apic_2 | 194 | 199 | PF02991 | 0.561 |
LIG_LIR_Gen_1 | 190 | 201 | PF02991 | 0.445 |
LIG_LIR_Gen_1 | 292 | 302 | PF02991 | 0.532 |
LIG_LIR_Nem_3 | 167 | 172 | PF02991 | 0.311 |
LIG_LIR_Nem_3 | 190 | 196 | PF02991 | 0.568 |
LIG_LIR_Nem_3 | 292 | 298 | PF02991 | 0.530 |
LIG_LYPXL_yS_3 | 46 | 49 | PF13949 | 0.539 |
LIG_PDZ_Class_3 | 322 | 327 | PF00595 | 0.753 |
LIG_Rb_LxCxE_1 | 151 | 168 | PF01857 | 0.287 |
LIG_SH2_STAT5 | 172 | 175 | PF00017 | 0.301 |
LIG_SH2_STAT5 | 301 | 304 | PF00017 | 0.575 |
LIG_SH2_STAT5 | 69 | 72 | PF00017 | 0.358 |
LIG_SH2_STAT5 | 8 | 11 | PF00017 | 0.605 |
LIG_SH3_3 | 42 | 48 | PF00018 | 0.554 |
LIG_SUMO_SIM_anti_2 | 151 | 159 | PF11976 | 0.522 |
LIG_SUMO_SIM_par_1 | 25 | 31 | PF11976 | 0.437 |
LIG_TRAF2_1 | 184 | 187 | PF00917 | 0.345 |
LIG_TRAF2_1 | 306 | 309 | PF00917 | 0.545 |
LIG_TYR_ITIM | 44 | 49 | PF00017 | 0.302 |
LIG_Vh1_VBS_1 | 15 | 33 | PF01044 | 0.371 |
LIG_WRC_WIRS_1 | 58 | 63 | PF05994 | 0.430 |
MOD_CK1_1 | 293 | 299 | PF00069 | 0.382 |
MOD_CK1_1 | 319 | 325 | PF00069 | 0.784 |
MOD_CK1_1 | 7 | 13 | PF00069 | 0.650 |
MOD_CK2_1 | 123 | 129 | PF00069 | 0.678 |
MOD_CK2_1 | 181 | 187 | PF00069 | 0.540 |
MOD_CK2_1 | 258 | 264 | PF00069 | 0.551 |
MOD_CK2_1 | 288 | 294 | PF00069 | 0.552 |
MOD_CK2_1 | 319 | 325 | PF00069 | 0.532 |
MOD_GlcNHglycan | 178 | 181 | PF01048 | 0.374 |
MOD_GlcNHglycan | 189 | 192 | PF01048 | 0.454 |
MOD_GlcNHglycan | 207 | 210 | PF01048 | 0.283 |
MOD_GlcNHglycan | 255 | 258 | PF01048 | 0.666 |
MOD_GlcNHglycan | 34 | 37 | PF01048 | 0.570 |
MOD_GSK3_1 | 187 | 194 | PF00069 | 0.365 |
MOD_GSK3_1 | 211 | 218 | PF00069 | 0.595 |
MOD_GSK3_1 | 28 | 35 | PF00069 | 0.531 |
MOD_GSK3_1 | 315 | 322 | PF00069 | 0.521 |
MOD_GSK3_1 | 4 | 11 | PF00069 | 0.636 |
MOD_N-GLC_1 | 181 | 186 | PF02516 | 0.500 |
MOD_N-GLC_2 | 57 | 59 | PF02516 | 0.247 |
MOD_NEK2_1 | 161 | 166 | PF00069 | 0.416 |
MOD_PIKK_1 | 191 | 197 | PF00454 | 0.305 |
MOD_PIKK_1 | 75 | 81 | PF00454 | 0.351 |
MOD_PIKK_1 | 9 | 15 | PF00454 | 0.412 |
MOD_PKA_2 | 247 | 253 | PF00069 | 0.617 |
MOD_PKA_2 | 315 | 321 | PF00069 | 0.737 |
MOD_Plk_1 | 123 | 129 | PF00069 | 0.576 |
MOD_Plk_1 | 161 | 167 | PF00069 | 0.551 |
MOD_Plk_1 | 293 | 299 | PF00069 | 0.576 |
MOD_Plk_2-3 | 234 | 240 | PF00069 | 0.607 |
MOD_Plk_4 | 123 | 129 | PF00069 | 0.678 |
MOD_Plk_4 | 161 | 167 | PF00069 | 0.418 |
MOD_Plk_4 | 168 | 174 | PF00069 | 0.480 |
MOD_Plk_4 | 57 | 63 | PF00069 | 0.408 |
MOD_ProDKin_1 | 197 | 203 | PF00069 | 0.457 |
MOD_SUMO_for_1 | 235 | 238 | PF00179 | 0.561 |
MOD_SUMO_rev_2 | 111 | 119 | PF00179 | 0.331 |
MOD_SUMO_rev_2 | 228 | 237 | PF00179 | 0.382 |
MOD_SUMO_rev_2 | 278 | 283 | PF00179 | 0.535 |
TRG_ENDOCYTIC_2 | 46 | 49 | PF00928 | 0.546 |
TRG_NES_CRM1_1 | 88 | 102 | PF08389 | 0.544 |
TRG_Pf-PMV_PEXEL_1 | 211 | 215 | PF00026 | 0.338 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P915 | Leptomonas seymouri | 48% | 100% |
A0A0S4IVP5 | Bodo saltans | 28% | 100% |
A0A1X0P0S9 | Trypanosomatidae | 33% | 100% |
A0A3R7NVI0 | Trypanosoma rangeli | 29% | 100% |
A0A3S7XC03 | Leishmania donovani | 65% | 100% |
A4IDX9 | Leishmania infantum | 65% | 100% |
D0A431 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 27% | 100% |
E9ATZ9 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 65% | 99% |
Q4Q0J6 | Leishmania major | 63% | 100% |
V5DK35 | Trypanosoma cruzi | 33% | 99% |